BC Week In Review | Jun 25, 2012
Company News

Stellar Pharmaceuticals, Theramed Corp. sales and marketing update

Stellar received exclusive, Canadian rights from Theramed to Collatamp G, which is approved for local hemostasis of capillary, parenchymatous and seeping hemorrhages in areas with a high risk of infection. Collatamp is a lyophilized collagen...
BC Week In Review | Aug 27, 2007
Company News

EUSA, Innocoll deal

EUSA acquired ex-U.S. rights to Innocoll's antibiotic and pain control products outside of the U.S., as well as Innocoll's European sales and marketing infrastructure. The products include surgical implant Collatamp G, a collagen matrix with...
Items per page:
1 - 2 of 2